Koyfin Home > Directory > Health Care > Accelerate Diagnosti > EBITDA Margin

Accelerate Diagnosti EBITDA Margin Chart (AXDX)

Accelerate Diagnosti annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Accelerate Diagnosti EBITDA Margin for the quarter ending June 06, 2020 was $-702m a -6.86% increase of 48m year over year
  • Accelerate Diagnosti EBITDA Margin for the last 12 months ending June 06, 2020 was $-651m a -43.91% increase of 286m year over year
  • Accelerate Diagnosti Annual EBITDA Margin for 2019 was $-755m a -81.66% increase of 617m from 2018
  • Accelerate Diagnosti Annual EBITDA Margin for 2018 was $-1,372m a -8.14% increase of 112m from 2017
  • Accelerate Diagnosti Annual EBITDA Margin for 2017 was $-1,484m a -1,657.19% increase of 24,593m from 2016
Other Margins & Efficiency Metrics:
  • Accelerate Diagnosti Return on Capital % for the quarter ending September 09, 2018 was -23.88 a -35.88% increase of 8.57 year over year
  • Accelerate Diagnosti Return on Equity % for the quarter ending September 09, 2018 was -102.61 a 48.90% decrease of -50.18 year over year
View Chart On Koyfin

Quarterly AXDX EBITDA Margin Data

06/2020$-702m
03/2020$-725m
12/2019$-505m
09/2019$-750m
06/2019$-968m
03/2019$-1,040m
12/2018$-1,040m
09/2018$-1,380m
06/2018$-1,175m
03/2018$-2,532m

Annual AXDX EBITDA Margin Data

2019$-755m
2018$-1,372m
2017$-1,484m
2016$-26,077m
2015$-29,767m
2014$-24,671m
2013$-31,119m
2012$-16,811m
2012$-1,335m
2011$-14m